WEGOVY (semaglutide) tablets, for oral use
One of the most surprising facts about GLP-1 medications is that hypothyroidism by itself is not typically a reason to avoid them
This means we start you on the smallest possible dose and only increase it once your body has fully adjusted
receives funding from the European Research Council (ERC-CoG Trusted no.101044445), the German Research Foundation (DFG TRR296, TRR152, SFB1123 and GRK 2816/1) and the German Center for Diabetes Research (DZD e.V.)
Staying on Wegovy makes more sense if youre still losing weight consistently, if you still have dose increases available (you havent reached 2.4 mg yet), if your insurance covers Wegovy well but doesnt cover Zepbound, or if youre tolerating Wegovy without significant issues and dont want to risk a medication change
Given the complexity, working with a provider who is experienced with this population is helpful